Cargando…

Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus

Hepatocellular carcinoma (HCC) with inferior vena cava (IVC) tumor thrombus rarely occurs, its prognosis is extremely poor. A 49-year-old locally advanced HCC male with tumor thrombus extension into the IVC and the right atrium was successfully treated with stereotactic body radiotherapy (SBRT). A r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shui, Yongjie, Zhu, Xiaoping, Wu, Jianjun, Liang, Tingbo, Wei, Qichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614854/
https://www.ncbi.nlm.nih.gov/pubmed/31308700
http://dx.doi.org/10.2147/OTT.S208560
_version_ 1783433259537924096
author Shui, Yongjie
Zhu, Xiaoping
Wu, Jianjun
Liang, Tingbo
Wei, Qichun
author_facet Shui, Yongjie
Zhu, Xiaoping
Wu, Jianjun
Liang, Tingbo
Wei, Qichun
author_sort Shui, Yongjie
collection PubMed
description Hepatocellular carcinoma (HCC) with inferior vena cava (IVC) tumor thrombus rarely occurs, its prognosis is extremely poor. A 49-year-old locally advanced HCC male with tumor thrombus extension into the IVC and the right atrium was successfully treated with stereotactic body radiotherapy (SBRT). A radiation dose of 40 Gy/5 fractions was delivered to the thrombus in 5 days. Contrast-enhanced magnetic resonance imaging one month after SBRT demonstrated no thrombus in IVC and the right atrium, and the huge lesion on right lobe also shrank. No severe adverse effect, eg, pulmonary embolism, was encountered. After controlling the thrombus, this patient has the opportunity to receive subsequent transarterial chemoembolization procedure in time, and avoided disease progression outside the irradiation volume. We reported a HCC case with extensive IVC and atrium tumor thrombus successfully treated by SBRT, the effectiveness and potential severe adverse effects were discussed.
format Online
Article
Text
id pubmed-6614854
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66148542019-07-15 Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus Shui, Yongjie Zhu, Xiaoping Wu, Jianjun Liang, Tingbo Wei, Qichun Onco Targets Ther Case Report Hepatocellular carcinoma (HCC) with inferior vena cava (IVC) tumor thrombus rarely occurs, its prognosis is extremely poor. A 49-year-old locally advanced HCC male with tumor thrombus extension into the IVC and the right atrium was successfully treated with stereotactic body radiotherapy (SBRT). A radiation dose of 40 Gy/5 fractions was delivered to the thrombus in 5 days. Contrast-enhanced magnetic resonance imaging one month after SBRT demonstrated no thrombus in IVC and the right atrium, and the huge lesion on right lobe also shrank. No severe adverse effect, eg, pulmonary embolism, was encountered. After controlling the thrombus, this patient has the opportunity to receive subsequent transarterial chemoembolization procedure in time, and avoided disease progression outside the irradiation volume. We reported a HCC case with extensive IVC and atrium tumor thrombus successfully treated by SBRT, the effectiveness and potential severe adverse effects were discussed. Dove 2019-07-04 /pmc/articles/PMC6614854/ /pubmed/31308700 http://dx.doi.org/10.2147/OTT.S208560 Text en © 2019 Shui et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Shui, Yongjie
Zhu, Xiaoping
Wu, Jianjun
Liang, Tingbo
Wei, Qichun
Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
title Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
title_full Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
title_fullStr Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
title_full_unstemmed Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
title_short Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
title_sort stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614854/
https://www.ncbi.nlm.nih.gov/pubmed/31308700
http://dx.doi.org/10.2147/OTT.S208560
work_keys_str_mv AT shuiyongjie stereotacticbodyradiotherapyastheinitialtreatmentforhepatocellularcarcinomawithextensiveinferiorvenacavaandatriumtumorthrombus
AT zhuxiaoping stereotacticbodyradiotherapyastheinitialtreatmentforhepatocellularcarcinomawithextensiveinferiorvenacavaandatriumtumorthrombus
AT wujianjun stereotacticbodyradiotherapyastheinitialtreatmentforhepatocellularcarcinomawithextensiveinferiorvenacavaandatriumtumorthrombus
AT liangtingbo stereotacticbodyradiotherapyastheinitialtreatmentforhepatocellularcarcinomawithextensiveinferiorvenacavaandatriumtumorthrombus
AT weiqichun stereotacticbodyradiotherapyastheinitialtreatmentforhepatocellularcarcinomawithextensiveinferiorvenacavaandatriumtumorthrombus